![Kelly Chow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Kelly Chow
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Belharra Therapeutics, Inc.
![]() Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Geschäftsführer | 01.01.2022 | - |
Karriereverlauf von Kelly Chow
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Chief Operating Officer | 1 |
Sektoral
Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Belharra Therapeutics, Inc.
![]() Belharra Therapeutics, Inc. Medical/Nursing ServicesHealth Services Belharra Therapeutics, Inc. is a drug discovery company that utilizes a unique photoaffinity-based chemoproteomics platform to identify novel small molecule drug candidates for previously difficult-to-treat diseases and conditions. The company is based in San Diego, CA, with its primary lab and offices located in the area. Belharra's proprietary discovery engine allows for the identification of small molecule starting points for drug development on any protein, in any conformational state, and in any cell type. The company was founded in 2021 by John Teijaro, Christopher G. Parker, Stuart L. Schreiber, and Benjamin F. Cravatt, and has since been led by CEO Jeffrey Jonker. | Health Services |
- Börse
- Insiders
- Kelly Chow
- Erfahrung